Patent Assignment
Reel/Frame 059884/0918
Assignment of Assignor's Interest
Recorded: 2022-05-10
Pages: 3
Assignee
CURE PHARMACEUTICAL CORPORATION
1620 BEACON PLACE, OXNARD, CALIFORNIA, 93033
Covered Property
(1)
Oral Soluble Film Containing Sildenafil Citrate
Application:
17/488,610 →
Publication:
US 2022/0023198
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 22, 2022
From: CURE PHARMACEUTICAL CORPORATION
To: TF TECH VENTURES
Reel/Frame 060598/0016 →
Corrective Assignment to Correct the Receiving Party Name Which Should Read Tf Tech Ventures, Inc. and Not Tf Tech Ventures Previously Recorded at Reel: 060598 Frame: 0016. Assignor(S) Hereby Confirms the Assignment.
Jul 12, 2023
From: CURE PHARMACEUTICAL CORPORATION
To: TF TECH VENTURES, INC.
Reel/Frame 064256/0361 →
Change of Name
Jul 17, 2023
From: TF TECH VENTURES, INC.
To: CURE PHARMACEUTICAL, INC.
Reel/Frame 064286/0450 →
Lien
Jan 28, 2025
From: CURE PHARMACEUTICAL, INC.
To: CUREX PHARMACEUTICAL MEXICO S.A.P.I. DE C.V.
Reel/Frame 070027/0201 →